Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Apyx Medical (APYX) Gross Profit (2016 - 2025)

Historic Gross Profit for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $8.3 million.

  • Apyx Medical's Gross Profit rose 1931.26% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year increase of 233.25%. This contributed to the annual value of $29.4 million for FY2024, which is 1303.06% down from last year.
  • Latest data reveals that Apyx Medical reported Gross Profit of $8.3 million as of Q3 2025, which was up 1931.26% from $7.1 million recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Gross Profit ranged from a high of $12.2 million in Q4 2021 and a low of $5.7 million during Q1 2025
  • In the last 5 years, Apyx Medical's Gross Profit had a median value of $7.6 million in 2023 and averaged $7.7 million.
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 25978.99% in 2021, then tumbled by 3217.84% in 2022.
  • Over the past 5 years, Apyx Medical's Gross Profit (Quarter) stood at $12.2 million in 2021, then tumbled by 32.18% to $8.2 million in 2022, then increased by 8.35% to $8.9 million in 2023, then increased by 0.39% to $9.0 million in 2024, then decreased by 7.44% to $8.3 million in 2025.
  • Its Gross Profit stands at $8.3 million for Q3 2025, versus $7.1 million for Q2 2025 and $5.7 million for Q1 2025.